We are live on
!
Find out more
CCM
Catapult Capital Management Portfolio holdings
AUM
$265M
1-Year Est. Return
21.83%
This Fund
S&P 500
This Quarter
Est. Return
+5.74%
1 Year Est. Return
+21.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$696M
AUM Growth
-$122M
(-15%)
Cap. Flow
-$135M
Cap. Flow
% of AUM
-19.45%
Top 10 Holdings %
Top 10 Hldgs %
23.76%
Holding
329
New
119
Increased
34
Reduced
64
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$23.2M |
| 2 |
PepsiCo
PEP
|
+$13.1M |
| 3 |
AbbVie
ABBV
|
+$10.1M |
| 4 |
Elevance Health
ELV
|
+$9.59M |
| 5 |
Abbott
ABT
|
+$8.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$22.4M |
| 2 |
Pfizer
PFE
|
+$18M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$13.1M |
| 4 |
Pediatrix Medical
MD
|
+$11.2M |
| 5 |
Danaher
DHR
|
+$11.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.68% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Industrials | 7.26% |
| 4 | Consumer Staples | 5.08% |
| 5 | Communication Services | 3.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
PUT
Seagate
STX
$193B
| $2.38M | 0.34% |
+50,000
| New | +$2.76M |
|
|
NUVA
102
DELISTED
NuVasive, Inc.
NUVA
| $2.37M | 0.34% |
+50,000
| New | +$2.34M |
|
103
Wabtec
WAB
$49.4B
| $2.36M | 0.34% |
+25,054
| New | +$2.46M |
|
104
CALL
Allison Transmission
ALSN
$9.57B
| $2.34M | 0.34% |
+80,000
| New | +$2.49M |
|
105
Restaurant Brands International
QSR
$25.8B
| $2.34M | 0.34% |
61,275
-3,427
| -5% | -$135K |
|
106
L3Harris
LHX
$50.7B
| $2.29M | 0.33% |
29,745
+18,474
| +164% | +$1.47M |
|
|
KSU
107
CALL
DELISTED
Kansas City Southern
KSU
| $2.28M | 0.33% |
+25,000
| New | +$2.47M |
|
|
AXE
108
CALL
DELISTED
Anixter International Inc
AXE
| $2.28M | 0.33% |
35,000
-5,000
| -13% | -$354K |
|
109
TE Connectivity
TEL
$59.9B
| $2.27M | 0.33% |
35,378
-3,540
| -9% | -$245K |
|
|
PARA
110
CALL
DELISTED
Paramount Global Class B
PARA
| $2.22M | 0.32% |
40,000
-10,000
| -20% | -$604K |
|
111
CALL
Nucor
NUE
$58.5B
| $2.2M | 0.32% |
+50,000
| New | +$2.4M |
|
|
CLVS
112
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.2M | 0.32% |
+25,000
| New | +$2.14M |
|
|
HUB.B
113
DELISTED
HUBBELL INC CL-B
HUB.B
| $2.19M | 0.32% |
20,248
-15,314
| -43% | -$1.68M |
|
114
Crown Holdings
CCK
$12.9B
| $2.18M | 0.31% |
+41,262
| New | +$2.27M |
|
|
ESL
115
DELISTED
Esterline Technologies
ESL
| $2.16M | 0.31% |
+22,685
| New | +$2.43M |
|
|
MHFI
116
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $2.16M | 0.31% |
21,479
-23,702
| -52% | -$2.48M |
|
|
X
117
CALL
DELISTED
US Steel
X
| $2.06M | 0.3% |
+100,000
| New | +$2.45M |
|
118
AMN Healthcare
AMN
$1.35B
| $2.05M | 0.3% |
+65,000
| New | +$1.7M |
|
|
MNTA
119
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $2.05M | 0.3% |
+90,000
| New | +$1.79M |
|
120
CALL
New York Times
NYT
$12.3B
| $2.05M | 0.29% |
+150,000
| New | +$2.07M |
|
121
CALL
Marvell Technology
MRVL
$165B
| $1.98M | 0.28% |
+150,000
| New | +$2.15M |
|
122
Canadian Pacific Kansas City
CP
$78.3B
| $1.98M | 0.28% |
61,620
-42,855
| -41% | -$1.53M |
|
123
CALL
Corning
GLW
$116B
| $1.97M | 0.28% |
+100,000
| New | +$2.14M |
|
|
EXAM
124
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $1.96M | 0.28% |
50,000
+7,493
| +18% | +$308K |
|
125
Textron
TXT
$15B
| $1.95M | 0.28% |
43,725
-54,673
| -56% | -$2.48M |
|
Similar funds
LOCB
AF
TCOTO
DCM
SCA
LPVHS
ATC
TFF
Catapult Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Catapult Capital Management held 329 positions worth $696M, down 15% from $818M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Catapult Capital Management withdrew a net $135M in Q2 2015, closing 111 positions and reducing 64 holdings. Its most notable exit was Pfizer, an estimated $18M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Catapult Capital Management opened a new position in Zoetis worth $23.5M.
- Catapult Capital Management's largest Q2 2015 buy was Zoetis: 486,665 shares worth $23.5M.
- Catapult Capital Management added most to AbbVie in Q2 2015, an estimated $10.1M increase.
- Catapult Capital Management's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $22.4M.
- Catapult Capital Management fully exited Pfizer in Q2 2015, selling an estimated $18M.
- Catapult Capital Management's ten largest holdings make up 24% of its $696M portfolio in Q2 2015.
- Catapult Capital Management opened 119 new positions and closed 111 in Q2 2015.
- Catapult Capital Management's portfolio value fell 15% quarter-over-quarter to $696M.
Based on Catapult Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.